Related Experiment Video
Updated: Mar 7, 2026

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Initial Clinical Experience with the First FDA-Approved sEEG-Guided Radiofrequency Ablation System Featuring
Baltazar Zavala1,2, Efstathios Kondylis1,2, Juan Bulacio1,3
1Cleveland Clinic Epilepsy Center, Cleveland, Ohio, USA.
New FDA-approved technology enables safe stereoelectroencephalography-guided radiofrequency ablation (sEEG-RFA) for epilepsy treatment. This diagnostic tool shows promise for reducing seizures and guiding surgical decisions in refractory cases.
Area of Science:
- Neurosurgery
- Epileptology
- Medical Technology
Background:
- Stereoelectroencephalography-guided radiofrequency ablation (sEEG-RFA) is an established technique for creating lesions in epileptic networks, primarily used in Europe.
- Lack of FDA-approved technology for in situ sEEG electrode use has limited its adoption in the United States.
- Recent FDA approval of a new hollow sEEG electrode and OneRF generator (NeuroOne) with real-time thermal monitoring addresses this limitation.
More Related Videos
04:58Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
Published on: August 25, 2022
05:43Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling
Published on: April 19, 2024